About the Authors
- David O'Sullivan
-
Contributed equally to this work with: David O'Sullivan, Laura Green
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Laura Green
-
Contributed equally to this work with: David O'Sullivan, Laura Green
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Sarrabeth Stone
-
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Pirooz Zareie
-
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Marie Kharkrang
-
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Dahna Fong
-
Affiliation School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand
- Bronwen Connor
-
Affiliation Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
- Anne Camille La Flamme
-
* E-mail: anne.laflamme@vuw.ac.nz
Affiliations School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand, Malaghan Institute of Medical Research, Wellington, New Zealand
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: ACL, DO, and BC hold a patent for the use of risperidone and clozapine during MS.
Author Contributions
Conceived and designed the experiments: DO LG SS PZ MK DF BC ACL. Performed the experiments: DO LG SS PZ MK DF. Analyzed the data: DO LG SS PZ BC ACL. Contributed to the writing of the manuscript: DO LG ACL.